Skip to main content
CDC Website

English

Tuberculosis Drug Information Guide

The Tuberculosis Drug Information Guide, 2nd edition, is derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008. Two additional drugs, ofloxacin and clarithromycin (which are used primarily outside of the US), have been included. This Guide can help any physician, nurse, or pharmacist who participates in the management of patients with TB or LTBI.

Systematic Screening for Active Tuberculosis: Principles and Recommendations

This document sets out basic principles for prioritizing risk groups and choosing a screening approach. It emphasizes the importance of assessing the epidemiological situation, adapting approaches to local situations, integrating TB screening into other health-promotion activities, minimizing the risk of harm to individuals, and engaging in continual monitoring and evaluation.

Tuberculosis Laboratory Biosafety Manual

The recommendations in this manual are based on assessments of the risks associated with different technical procedures performed in different types of TB laboratories. The manual describes the basic requirements for facilities and practices, which can be adapted to follow local or national regulations or as the result of a risk assessment.